Tech Center 1600 • Art Units: 1618 1641
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18361064 | NANO- OR MICROPARTICLE COMPRISING A POLYVINYL ALCOHOL MATRIX AND DISPERSED THEREIN, FERRITE, METHOD FOR PRODUCING THE SAME AND USES THEREOF | Non-Final OA | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES |
| 18249663 | MONOAMINE OXIDASE BLOCKADE THERAPY FOR TREATING CANCER THROUGH REGULATING ANTITUMOR T CELL IMMUNITY | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18052354 | CUSTOMIZABLE DOSAGE FORMS CONTAINING SIMETHICONE | Non-Final OA | Kenvue Brands LLC |
| 17475794 | NON-FIBROUS FILM AND CELL SHEET | Non-Final OA | Industrial Technology Research Institute |
| 18612007 | Carrier Systems For Cannabinoids | Final Rejection | Fertin Pharma A/S |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy